SBIR-STTR Award

Electromagnetic Tracking of Tumors for Radiotherapy
Award last edited on: 5/27/09

Sponsored Program
STTR
Awarding Agency
NIH : NLM
Total Award Amount
$40,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Martin J Murphy

Company Information

Calypso Medical Technologies Inc (AKA: Calamari Medical, Inc)

2101 Fourth Avenue Suite 1550
Seattle, WA 98121
   (206) 254-0600
   info@calypsomedical.com
   www.calypsomedical.com

Research Institution

----------

Phase I

Contract Number: 1R41LM008750-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2004
Phase I Amount
$40,000
This project will analyze the feasibility of using the Calypso electromagnetic localization system to track tumors that move with breathing. Such a capability will allow the system to operate through a control system to keep an external radiation therapy beam on target while the patient breathes. The Calypso system uses small electromagnetic coils that can be implanted in a tumor and then located remotely, with millimeter-scale accuracy, by a transmitter/receiver system positioned above the patient. This technology was initially developed to replace image-based localization of the tumor site for patients undergoing external-beam radiotherapy, and to provide continuous tracking during the course of irradiation. Because the system can sample the tumor position at a rate of ten measurements per second, it is capable in principle of real-time tumor tracking. The feasibility of applying real-time tracking to lung radiotherapy will be analyzed by characterizing the accuracy and time response of the Calypso measurement system, designing and characterizing a control system to translate the Calypso measurement into beam control data while accomodating system lag time, and then assessing the complete control process performance against measured clinical data for tumor motion during free breathing. Electromagnetic tumor tracking will supplement and potentially replace the intensive radiological imaging that is presently needed to locate moving tumors during treatment. This will result in a significant reduction in non-therapeutic radiation dose to the patient while simplifying the tumor localization process. The augmented Calypso targeting system will be designed for integration with existing radiation therapy systems to provide enhanced beam targeting capability.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----